Lupus Mechanisms and Targets Award (LMTA) Archives

2019 Funded Grants

Targeting the Inactive X for Correcting Dosage Imbalances in Lupus

Montserrat Anguera, PhD
University of Pennsylvania School of Veterinary Medicine, Philadelphia

Intrinsic B cell epigenetic mediators as therapeutic targets in lupus

Paolo Casali, MD
University of Texas Health Science Center at San Antonio

Cytokine Immunoregulatory Strategy to Target SLE Autoreactive B Cells

Hui-Chen Hsu, PhD
University of Alabama at Birmingham

Targeting Follicular Helper T cell Metabolism in Lupus

Hongbo Chi, PhD
St. Jude Children's Research Hospital, Memphis, Tennessee

Relieving ER Stress in Lupus Neutrophils

Jason Knight, MD, PhD
University of Michigan, Ann Arbor

Ptprz: A Therapeutic Target for Lupus Nephritis

Vicki Kelley, PhD
Harvard Medical School

Targeting Follicular Helper T Cells in Lupus

Joseph Craft, MD
Yale School of Medicine

The cyclic GAMP Pathway in SLE

Keith Elkon, MD
University of Washington

Targeting Interferon-Stimulated Transcription as a Novel Lupus Therapy

David Levy, PhD
NYU School of Medicine

PTPN22 function in human B cells and inhibition to reset tolerance in SLE

Eric Meffre, PhD
Yale School of Medicine

Targeting peripheral T cell-B cell interactions in SLE

Deepak Rao, MD, PhD
Harvard Medical School

Targeting the CXCR3 Chemokine Axis in Cutaneous Lupus

Jillian Richmond, PhD
University of Massachusetts Medical School

Mammalian free glycan, glycocalyx and anti-glycan antibody in lupus

Nan Yan, PhD
University of Texas Southwestern Medical Center

Targeting Endogenous Glomerular Repair in Lupus Nephritis

Janos Peti-Peterdi, MD, PhD
Keck School of Medicine of University of Southern California

Defining New Targets in lupus Through Identification of Non-coding SNPs

Peter A. Nigrovic, MD
Brigham and Women's Hospital, Inc

ALCAM in Lupus

Chandra Mohan, MD, PhD
University of Houston

Characterization of STING SAVI Gain of Function Mutations in Mice.

Katherine Fitzgerald, PhD
University of Massachusetts Medical School

Targeting the Inactive X Chromosome in Lupus

Laura Carrel, PhD
The Pennsylvania State University College of Medicine

The Role of Bacterial Infections in the Pathogenesis of Lupus

Roberto Caricchio, MD
Temple University

Finding Druggable Pathways Affected by the R90H-NCF1 SLE Risk Variants

Betty Tsao, PhD
Medical University of South Carolina

Identification of endogenous nucleic acids as targets in lupus